LONDON BROKER RATINGS: Oddo BHF cuts Wizz Air and Ryanair
6th Feb 2026 09:37
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
(Alliance News) - Stock prices in London were lower at midday on Tuesday, as an earlier rally in the FTSE 100, which sent it to a new intraday record, faded while the price of gold rebounded after recent falls. Read More
(Alliance News) - AstraZeneca PLC on Tuesday reported mixed news with progress for its cancer treatment Datroway, while US regulatory authorities requested more information on autoimmune disease drug Saphnelo before progressing its application. Read More
(Alliance News) - AG Barr reports revenue growth and buys soft drink brands Fentimans and Frobishers, while Filtronic expects to meet market expectations despite lower interim earnings. Read More
(Alliance News) - The FTSE 100 shrugged off a weak start, and further volatility in metals and oil prices, to hit new highs on Monday, amid optimism in the manufacturing sector on either side of the pond. Read More
(Alliance News) - Stock prices in London were mixed at midday on Monday, as the FTSE 100 recovered from its earlier fall as the decline in metal prices eased. Read More
(Alliance News) - AstraZeneca PLC on Monday said Imfinzi, in combination with chemotherapy, has been recommended for approval in the EU for the treatment of adult patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction cancers. Read More
(Alliance News) - UK annual house price growth rises more than expected in January, while AstraZeneca starts trading in New York and FitzWalter Capital says it does not intend to make an offer for Auction Technology Group. Read More
(Alliance News) - AstraZeneca PLC on Friday said it has expands its weight-management pipeline by collaborating with China's CSPC Pharmaceuticals Group Ltd to develop next-generation injectable therapies for obesity and type 2 diabetes. Read More
(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 little changed as investors digested geopolitical developments around UK-China relations and heavy flow of European economic data, while Asian markets closed lower. Read More
(Alliance News) - AstraZeneca unveils an up-to-USD3.5 billion obesity-drug collaboration with CSPC, and LSEG signs a strategic cooperation pact with ICBC during UK Prime Minister Keir Starmer's visit to China, while Airtel Africa posts strong nine-month growth. Read More
(Alliance News) - US President Donald Trump warned it would be "dangerous" for the UK to do business with China, as Keir Starmer moves to strengthen economic ties with Beijing on the final day of his visit. Read More
(Alliance News) - Pharmaceutical firm AstraZeneca PLC on Thursday unveiled plans to invest USD15 billion in China through to 2030, in an announcement that coincides with UK Prime Minister Keir Starmer's visit to Beijing. Read More
(Alliance News) - The FTSE 100 fell on Wednesday, and the oil price climbed, amid fresh geopolitical uncertainty, while the S&P 500 briefly topped 7,000 for the first time ahead of tech earnings and the US rate call. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More
(Alliance News) - HSBC Holdings Chair Brendan Nelson is among senior business figures set to travel to China with UK Prime Minister Keir Starmer next week, as the government seeks to reset relations with Beijing, Sky News reported on Thursday. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Thursday said Chinese regulators have approved their jointly developed drug Enhertu to treat gastric cancer. Read More